Helen J Curtis
Dados Biográficos
| ID | 8210888 |
|---|---|
| NOME | Helen J Curtis |
| PRENOMES | Helen J |
| SOBRENOME | Curtis |
| ASSINATURA | CURTIS H J |
| AFILIAÇÕES | University of Oxford |
| ORCID | 0000-0003-3429-9576 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 3 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 3 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2020 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2021 |
| ÍNDICE H | 0 |
Ethnic differences in Sars-CoV-2 infection and Covid-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England
BACKGROUND: COVID-19 has disproportionately affected minority ethnic populations in the UK. Our aim was to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 outcomes during the first and second waves of the COVID-19 pandemic in England. METHODS: We conducted an observational cohort study of adults (aged ≥18 years) registered with primary care practices in England for whom electronic health records were available through the OpenSAF…
Factors associated with Covid-19-related death using OpenSafely
Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer
In England, the National Institute for Health and Care Excellence guideline for familial breast cancer recommends chemoprevention for women at high and moderate familial risk of breast cancer. However, prescribing of chemoprevention has not improved since the introduction of the guideline in 2013. The study aims to identify the current practice, in England, of familial cancer specialists offering chemoprevention and recommending prescribing in pr…
Sem obras proeminentes nesta página.
Factors associated with Covid-19-related death using OpenSafely
Specialist recommendation for chemoprevention medications in patients at familial risk of breast cancer
In England, the National Institute for Health and Care Excellence guideline for familial breast cancer recommends chemoprevention for women at high and moderate familial risk of breast cancer. However, prescribing of chemoprevention has not improved since the introduction of the guideline in 2013. The study aims to identify the current practice, in England, of familial cancer specialists offering chemoprevention and recommending prescribing in pr…
Ethnic differences in Sars-CoV-2 infection and Covid-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England
BACKGROUND: COVID-19 has disproportionately affected minority ethnic populations in the UK. Our aim was to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 outcomes during the first and second waves of the COVID-19 pandemic in England. METHODS: We conducted an observational cohort study of adults (aged ≥18 years) registered with primary care practices in England for whom electronic health records were available through the OpenSAF…
Medicine (3 obras) · Coronavirus disease 2019 (COVID-19) (2 obras) · COVID-19 and healthcare impacts (2 obras) · COVID-19 Clinical Research Studies (2 obras) · Disease (2 obras) · Infectious disease (medical specialty) (2 obras) · Internal Medicine (2 obras) · 2019-20 coronavirus outbreak (1 obras) · BRCA gene mutations in cancer (1 obras) · Breast cancer (1 obras)